EL
42
3
ABBV
66
4
MUR
33
4
VRTX
48
2
CI
48
5
CPB
44
2
BBY
49
-3
CAT
48
2
EMN
42
2
HES
44
4
KMI
46
-2
UNM
57
4
EW
37
-4
NAVI
30
-2
MOS
49
-9
EXPE
72
3
PCAR
42
3
BK
74
5
WDC
63
2
NUE
47
3
EL
42
3
ABBV
66
4
MUR
33
4
VRTX
48
2
CI
48
5
CPB
44
2
BBY
49
-3
CAT
48
2
EMN
42
2
HES
44
4
KMI
46
-2
UNM
57
4
EW
37
-4
NAVI
30
-2
MOS
49
-9
EXPE
72
3
PCAR
42
3
BK
74
5
WDC
63
2
NUE
47
3
Financhill
Back

ProShares UltraShort Financials Vs. Akero Therapeutics Industry Stock Comparison

Sell
41

SKF
ProShares UltraShort Financials

Last Price:
$29.82
Seasonality Move:
-3.28%
Buy
68

AKRO
Akero Therapeutics

Last Price:
$54.26
Seasonality Move:
26.74%
Sell
41
ProShares UltraShort Financials (SKF) is a Sell

Is ProShares UltraShort Financials a Buy, Sell or Hold?

  • The current ProShares UltraShort Financials [SKF] share price is $29.72. The Score for SKF is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SKF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $54.28. The Score for AKRO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SKF Stock Price Chart

What is ProShares UltraShort Financials's stock price today?

  • The ProShares UltraShort Financials share price today is $29.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SKF is experiencing selling pressure, which indicates risk of future bearish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $54.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

SKF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: -6580 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.65 - 31.29) Sell
Bollinger Bands (100): (30.17 - 35.03) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.09 Buy
Relative Strength Index (14 RSI): 70.44 Buy
Chaikin Money Flow: -1219058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.53 - 50.43) Buy
Bollinger Bands (100): (34.89 - 51.35) Buy

SKF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.17 Sell
20-day SMA: 30.16 Sell
50-day SMA: 32.78 Sell
200-day SMA: 35.13 Sell
8-day EMA: 30.15 Sell
20-day EMA: 30.6 Sell
50-day EMA: 31.81 Sell
200-day EMA: 36.42 Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.82 Buy
20-day SMA: 46 Buy
50-day SMA: 42.47 Buy
200-day SMA: 36.08 Buy
8-day EMA: 51.3 Buy
20-day EMA: 47.76 Buy
50-day EMA: 44.57 Buy
200-day EMA: 37.75 Buy

ProShares UltraShort Financials Earnings Growth & SKF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

ProShares UltraShort Financials Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):